TELCON RF PHARMACEUTICAL. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	16,615	62,827	70,587	97,672	110,233	255,964
Market Cap Growth	-64.21%	-10.99%	-27.73%	-11.39%	-56.93%	-50.53%
Enterprise Value	25,911	56,803	107,353	107,951	136,288	323,257
Last Close Price	2425.00	9170.00	15824.58	23534.68	27362.78	78853.32
PE Ratio	-	-	-	7.02	-	-
PS Ratio	0.39	1.46	1.86	2.69	3.96	6.76
PB Ratio	0.17	0.58	0.85	0.93	1.31	2.40
P/TBV Ratio	0.20	0.68	1.10	1.18	1.83	3.35
P/FCF Ratio	41.06	46.65	-	-	-	-
P/OCF Ratio	17.88	37.70	57.91	-	-	-
EV/Sales Ratio	0.60	1.32	2.84	2.97	4.90	8.54
EV/EBITDA Ratio	4.21	10.25	24.20	20.72	623.83	-
EV/EBIT Ratio	20.47	79.05	-	111.83	-	-
EV/FCF Ratio	64.03	42.18	-	-	-	-
Debt / Equity Ratio	0.41	0.32	0.67	0.26	0.36	0.53
Debt / EBITDA Ratio	7.00	6.18	12.55	5.26	138.58	-
Debt / FCF Ratio	98.40	25.45	-	-	-	-
Net Debt / Equity Ratio	0.09	0.02	0.55	0.16	0.24	0.31
Net Debt / EBITDA Ratio	1.58	0.39	10.29	3.25	94.03	-90.18
Net Debt / FCF Ratio	22.19	1.59	-12.18	-3.41	-7.05	-12.53
Asset Turnover	0.30	0.28	0.26	0.28	0.19	0.21
Inventory Turnover	6.41	6.56	5.55	5.57	4.99	6.71
Quick Ratio	0.79	0.89	0.27	0.56	0.47	0.55
Current Ratio	1.24	1.25	0.37	0.95	0.67	0.62
Return on Equity (ROE)	-10.00%	-11.91%	-28.18%	14.75%	-44.16%	-23.10%
Return on Assets (ROA)	0.34%	0.29%	-0.03%	0.46%	-1.77%	-1.62%
Return on Invested Capital (ROIC)	0.73%	0.60%	-0.06%	0.85%	-3.33%	-3.10%
Return on Capital Employed (ROCE)	0.80%	0.70%	-0.10%	0.90%	-4.80%	-4.20%
Earnings Yield	-49.95%	-18.23%	-37.29%	14.24%	-38.18%	-9.02%
FCF Yield	2.44%	2.14%	-5.31%	-5.07%	-2.64%	-1.02%
Buyback Yield / Dilution	-56.76%	-35.21%	20.93%	-8.89%	-56.33%	-2.65%